428 related articles for article (PubMed ID: 23750796)
1. Live-attenuated Yersinia pestis vaccines.
Wang X; Zhang X; Zhou D; Yang R
Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
[TBL] [Abstract][Full Text] [Related]
2. Rational considerations about development of live attenuated Yersinia pestis vaccines.
Sun W; Curtiss R
Curr Pharm Biotechnol; 2013; 14(10):878-86. PubMed ID: 24372254
[TBL] [Abstract][Full Text] [Related]
3. Developing live vaccines against plague.
Sun W; Roland KL; Curtiss R
J Infect Dev Ctries; 2011 Sep; 5(9):614-27. PubMed ID: 21918302
[TBL] [Abstract][Full Text] [Related]
4. Current challenges in the development of vaccines for pneumonic plague.
Smiley ST
Expert Rev Vaccines; 2008 Mar; 7(2):209-21. PubMed ID: 18324890
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK
mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353
[TBL] [Abstract][Full Text] [Related]
6. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W
FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022
[TBL] [Abstract][Full Text] [Related]
7. A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.
Oyston PC; Mellado-Sanchez G; Pasetti MF; Nataro JP; Titball RW; Atkins HS
Microb Pathog; 2010 May; 48(5):191-5. PubMed ID: 20096773
[TBL] [Abstract][Full Text] [Related]
8. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
9. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
[TBL] [Abstract][Full Text] [Related]
10. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
[TBL] [Abstract][Full Text] [Related]
11. Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.
Zhang Q; Wang Q; Tian G; Qi Z; Zhang X; Wu X; Qiu Y; Bi Y; Yang X; Xin Y; He J; Zhou J; Zeng L; Yang R; Wang X
Hum Vaccin Immunother; 2014; 10(2):368-77. PubMed ID: 24225642
[TBL] [Abstract][Full Text] [Related]
12. Identification of New Virulence Factors and Vaccine Candidates for
Andersson JA; Sha J; Erova TE; Fitts EC; Ponnusamy D; Kozlova EV; Kirtley ML; Chopra AK
Front Cell Infect Microbiol; 2017; 7():448. PubMed ID: 29090192
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
Philipovskiy AV; Smiley ST
Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
[TBL] [Abstract][Full Text] [Related]
14. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.
Sun W; Roland KL; Kuang X; Branger CG; Curtiss R
Infect Immun; 2010 Mar; 78(3):1304-13. PubMed ID: 20086087
[TBL] [Abstract][Full Text] [Related]
15. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
Branger CG; Fetherston JD; Perry RD; Curtiss R
Adv Exp Med Biol; 2007; 603():387-99. PubMed ID: 17966435
[TBL] [Abstract][Full Text] [Related]
16. Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine.
Bubeck SS; Dube PH
Clin Vaccine Immunol; 2007 Sep; 14(9):1235-8. PubMed ID: 17652523
[TBL] [Abstract][Full Text] [Related]
17. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.
Sun W; Six D; Kuang X; Roland KL; Raetz CR; Curtiss R
Vaccine; 2011 Apr; 29(16):2986-98. PubMed ID: 21320544
[TBL] [Abstract][Full Text] [Related]
18. Hereditary hemochromatosis restores the virulence of plague vaccine strains.
Quenee LE; Hermanas TM; Ciletti N; Louvel H; Miller NC; Elli D; Blaylock B; Mitchell A; Schroeder J; Krausz T; Kanabrocki J; Schneewind O
J Infect Dis; 2012 Oct; 206(7):1050-8. PubMed ID: 22896664
[TBL] [Abstract][Full Text] [Related]
19. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
[TBL] [Abstract][Full Text] [Related]
20. A dam mutant of Yersinia pestis is attenuated and induces protection against plague.
Robinson VL; Oyston PC; Titball RW
FEMS Microbiol Lett; 2005 Nov; 252(2):251-6. PubMed ID: 16188402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
